Erez Eitan

Erez Eitan, Ph.D., is the Chief Scientific Officer and co-founder of NeuroDex, a company developing blood tests for Alzheimer's disease and other types of dementia.12 He is a pioneering researcher in the field of exosomes, having been the first to study them at the National Institute on Aging (NIA).3

Professional Background

Dr. Eitan has an impressive scientific career:

• He has published over 27 peer-reviewed articles and developed novel methodologies in exosome research.2
• Prior to founding NeuroDex, he served as a senior scientist in a leading diagnostic company.2
• He has led research collaborations with several pharmaceutical companies and academic institutions.2

Education

Dr. Eitan's educational background includes:

• B.S. from Ben-Gurion University of the Negev, Israel (2008)
• MBA from Ben-Gurion University of the Negev, Israel (2012)
• Ph.D. from Ben-Gurion University of the Negev, Israel (2013)
• Postdoctoral research at the National Institute of Health (NIH) (completed in 2017)1

Current Work

At NeuroDex, Dr. Eitan is focused on validating extracellular vesicle-based blood tests for neurodegenerative diseases.5 His expertise in exosome biology and neurodegenerative disorders has led to his participation in prestigious conferences such as the Alzheimer's Association International Conference (AAIC) and workshops organized by the International Society for Extracellular Vesicles (ISEV).47

Dr. Eitan is described as an accomplished, productive, innovative, and collegial researcher.6 His work at NeuroDex aims to advance the field of diagnostics for neurodegenerative diseases, potentially improving early detection and treatment options for conditions like Alzheimer's and Parkinson's disease.